A proposal in the North American Free Trade Agreement (NAFTA) to set the length of biologic data exclusivity at ten years would harm patients, according to generic associations.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
26 January 2018 More than 100 organisations have expressed concerns over the North American Free Trade Agreement renegotiations, suggesting that the IP chapter should be abolished.
26 January 2018 More than 100 organisations have expressed concerns over the North American Free Trade Agreement renegotiations, suggesting that the IP chapter should be abolished.
26 January 2018 More than 100 organisations have expressed concerns over the North American Free Trade Agreement renegotiations, suggesting that the IP chapter should be abolished.